(Total Views: 566)
Posted On: 06/02/2020 12:58:50 PM
Post# of 154013
According to Dr. Pourhassan:
Received notice from FDA yesterday afternoon they will not give CytoDyn anymore EINDs for hospitals as they need the company to complete its trials.
They've checked on ClinicalTrials.gov and see no other company/pharma has received any more than 20 approvals whereas CytoDyn has more than 70 (he had more specific number).
https://clinicaltrials.gov/ct2/show/record/NC...iew=record
Amarex Dr. Kush Dhody, Director of all CytoDyn 's Clinical Trials spoke of enrollment numbers. He said they have filed two study results and plan to have them presented in the New England Journal of Medicine.
Received notice from FDA yesterday afternoon they will not give CytoDyn anymore EINDs for hospitals as they need the company to complete its trials.
They've checked on ClinicalTrials.gov and see no other company/pharma has received any more than 20 approvals whereas CytoDyn has more than 70 (he had more specific number).
https://clinicaltrials.gov/ct2/show/record/NC...iew=record
Amarex Dr. Kush Dhody, Director of all CytoDyn 's Clinical Trials spoke of enrollment numbers. He said they have filed two study results and plan to have them presented in the New England Journal of Medicine.
(0)
(0)
